These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13441925)

  • 1. [Proteic-anabolic action of 19-nortestosterone propionate].
    DONINI P; MONTEZEMOLO R
    Rass Clin Ter; 1957; 56(1):17-25. PubMed ID: 13441925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and experimental research on the anabolic action of 19-nortestosterone hemisuccinate].
    DE RITIS L; PICENI SERENI L
    Minerva Pediatr; 1961 Mar; 13():363-8. PubMed ID: 13720808
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new method of administration of 19-nortestosterone propionate].
    DONINI P; MONTEZEMOLO R
    Rass Clin Ter; 1958; 57(2):74-9. PubMed ID: 13579248
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of 19-nortestosterone propionate on hemopoiesis in the normal child].
    GELLI GP; DELLA SANTA L
    Minerva Pediatr; 1960 Nov; 12():1541-5. PubMed ID: 13704304
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with 19-nortestosterone-phenyl-propionate].
    NOWAKOWSKI H; PARADA J
    Dtsch Med Wochenschr; 1958 Aug; 83(34):1421-6. PubMed ID: 13573931
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of 19-nortestosterone propionate in pediatric practice].
    GIUSTI M; MORI S
    Rass Clin Ter; 1958; 57(2):66-73. PubMed ID: 13579247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials of 19-nortestosterone propionate].
    MORELLINI M; FERRARI S
    Rass Clin Ter; 1958; 57(3):107-17. PubMed ID: 13602133
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the behavior of 17-ketosteroids and 17-hydroxysteroids in children treated with 19-nortestosterone propionate].
    DELLA SANTA L; FRANCHI F
    Minerva Pediatr; 1961 May; 13():703-5. PubMed ID: 13721625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Data on the use of an anabolic steroid (4-chloro-19-nortestosterone acetate) in dystrophy of the infant and comparative behavior of the cutaneous envelopes].
    IAFUSCO F; BUFFA V
    Minerva Nipiol; 1960; 10():56-7. PubMed ID: 13717191
    [No Abstract]   [Full Text] [Related]  

  • 10. [Observations on the treatment of ascitogenic cirrhosis with anabolic steroids. The peritoneal reabsorption of plasma in animals treated with 4-chloro-19-nortestosterone].
    ADEZATI L; POLLERI A; MOLINELLI G; BESTAGNO M
    Arch Maragliano Patol Clin; 1961 Feb; 17():137-40. PubMed ID: 13681483
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of 19-nortestosterone sulphate and boldenone sulphate in urine from male horses using liquid chromatography/tandem mass spectrometry.
    Grace PB; Drake EC; Teale P; Houghton E
    Rapid Commun Mass Spectrom; 2008 Oct; 22(19):2999-3007. PubMed ID: 18777513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First results of the treatment of cortisone osteoporosis with the combination of a non-virilizing synthetic anabolic drug. 17-ethyl-19-nortestosterone, and desoxyribonucleic acid].
    ISEMEIN L; TABAU R; FOURNIER AM; VIGNOLI R
    Rev Rhum Mal Osteoartic; 1960 Dec; 27():547-58. PubMed ID: 13717970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations on the use of 19-nortestos-terone propionate; further contribution to the study of anabolic steroids].
    BASSI G
    Endocrinol Sci Cost; 1958; 24(5):392-400. PubMed ID: 13597848
    [No Abstract]   [Full Text] [Related]  

  • 14. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of the protein-anabolizing action as well as acute and chronic toxicity of 17-ethyl-19-nortestosterone].
    ASCHKENASY A
    Therapie; 1959; 14(2):332-49. PubMed ID: 13647450
    [No Abstract]   [Full Text] [Related]  

  • 16. [Two properties of methylestrenolone (17-alpha-methyl-19-nortestosterone): its effectiveness in the treatment of dysmenorrhea, its anabolic action].
    BEGNI-CALVET D
    Gynecol Prat; 1959; 10():261-72. PubMed ID: 13798272
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical research on progestational action of 17-alpha-ethynil-19-nortestosterone administered orally].
    BOCCI A
    Minerva Ginecol; 1957 Oct; 9(20):863-8. PubMed ID: 13516673
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of a new derivative of testosterone (dianbol) with anabolic action].
    SCALFI GF; PONTIGGIA P; DI STEF ANO A; ROSSI T
    Minerva Med; 1961 Feb; 52():393-4. PubMed ID: 13747033
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progestative effect and clinical applicability of ethinyl-nortestosterone and methyl-nortestosterone].
    WILL I
    Zentralbl Gynakol; 1958 Feb; 80(8):317-22. PubMed ID: 13558646
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro metabolism of a new derivative of testosterone with a marked anabolic action: 4-chlorotestosterone].
    SALA G; CASTEGNARO E
    Folia Endocrinol Mens Incretologia Incretoterapia; 1958 Jun; 11(3):348-53. PubMed ID: 13574260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.